Estrella Immunopharma Statistics
Total Valuation
ESLA has a market cap or net worth of $48.20 million. The enterprise value is $47.56 million.
| Market Cap | 48.20M |
| Enterprise Value | 47.56M |
Important Dates
The last earnings date was Monday, May 18, 2026, before market open.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESLA has 43.03 million shares outstanding. The number of shares has increased by 5.23% in one year.
| Current Share Class | 43.03M |
| Shares Outstanding | 43.03M |
| Shares Change (YoY) | +5.23% |
| Shares Change (QoQ) | +11.36% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 2.63% |
| Float | 14.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -271.46% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 251.42% |
| Weighted Average Cost of Capital (WACC) | 8.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ESLA has paid $825 in taxes.
| Income Tax | 825 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.29% in the last 52 weeks. The beta is 0.85, so ESLA's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +13.29% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 41.86 |
| Average Volume (20 Days) | 36,501 |
Short Selling Information
The latest short interest is 94,135, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 94,135 |
| Short Previous Month | 147,543 |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.67% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.25M |
| Pretax Income | -13.25M |
| Net Income | -13.25M |
| EBITDA | n/a |
| EBIT | -13.25M |
| Earnings Per Share (EPS) | -$0.35 |
Balance Sheet
The company has $1.93 million in cash and n/a in debt, with a net cash position of $1.93 million or $0.04 per share.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | n/a |
| Net Cash | 1.93M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | -5.27M |
| Book Value Per Share | -0.12 |
| Working Capital | -6.77M |
Cash Flow
| Operating Cash Flow | -8.02M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ESLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.23% |
| Shareholder Yield | -5.23% |
| Earnings Yield | -26.78% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | $12.00 |
| Price Target Difference | 971.43% |
| Analyst Consensus | n/a |
| Analyst Count | 0 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |